1. Home
  2. THM vs MLTX Comparison

THM vs MLTX Comparison

Compare THM & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Tower Hill Mines Ltd. (Canada)

THM

International Tower Hill Mines Ltd. (Canada)

HOLD

Current Price

$2.48

Market Cap

723.2M

Sector

N/A

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$15.80

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THM
MLTX
Founded
1978
2021
Country
Canada
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.2M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
THM
MLTX
Price
$2.48
$15.80
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$22.22
AVG Volume (30 Days)
2.9M
1.3M
Earning Date
03-11-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$5.95
52 Week High
$3.65
$62.75

Technical Indicators

Market Signals
Indicator
THM
MLTX
Relative Strength Index (RSI) 51.11 53.84
Support Level $2.39 $15.27
Resistance Level $2.79 $16.15
Average True Range (ATR) 0.38 0.74
MACD -0.04 -0.08
Stochastic Oscillator 18.44 66.14

Price Performance

Historical Comparison
THM
MLTX

About THM International Tower Hill Mines Ltd. (Canada)

International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project namely the Livengood Gold Project. It is located in northwest of Fairbanks, Alaska in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: